The Cochrane Schizophrenia Group

Prescribing as a junior doctor: do we know what we think we know?


Generic (Photo credit: Kraemer Family Library)

By Jennifer Nelson, Junior Doctor

“Evidence-based medicine” (EBM) is a term that is familiar to all junior doctors. But how often do we really consider EBM in our everyday practice? Are our decisions on how to treat patients made after careful consideration of the evidence, or do we simply follow trust protocols, or, more likely, go with a sort of “gut-feeling” about which treatment to offer?

Recently,  I was asked to review a patient with paranoid schizophrenia who is currently relapsing. He had been restarted on the antipsychotic Aripiprazole two weeks prior to me seeing him. He was starting to show signs of improvement; the voices were diminishing and he was gaining partial insight into the fact that the “pills” might be helping him. At the end of the interview, I decided to suggest an increase in the dose of Aripiprazole from 15mg to 20mg.  Read the rest of this entry »


A sociological understanding of diagnosis

ESRC Seminar Series: The role of diagnosis in health and wellbeing

A social science perspective on the social, economic and political costs and consequences of diagnosis

Date:  May 23rd 2013
Venue: University of East Anglia, Sports Park, Norwich
Cost:  Free. Read the rest of this entry »

Leave a comment »